CAS: 2143096-93-7
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Navitoclax-piperazine REF: TM-T12186CAS: 2143096-93-7 | 99.11% - 99.82% | 153,00 €~1.500,00 € | Vie 17 Ene 25 |
 | Navitoclax-piperazine REF: 3D-TKD09693CAS: 2143096-93-7 | Min. 95% | 324,00 €~4.008,00 € | Vie 28 Feb 25 |
Navitoclax-piperazine
CAS:2143096-93-7
Navitoclax-piperazine (ABT-263-piperazine) is an inhibitor of B-cell lymphoma extra large (BCL-XL).
Fórmula:
C47H56ClF3N6O5S3
Pureza:
99.11% - 99.82%
Forma y color:
Solid
Peso molecular:
973.63
Ref: TM-T12186
| 1mg | 153,00 € | ||
| 5mg | 302,00 € | ||
| 10mg | 513,00 € | ||
| 25mg | 809,00 € | ||
| 50mg | 1.111,00 € | ||
| 100mg | 1.500,00 € | ||
| 1mL*10mM (DMSO) | 529,00 € |
Entrega estimada en Estados Unidos, el Viernes 17 de Enero de 2025
Navitoclax-piperazine
CAS:2143096-93-7
Navitoclax-piperazine is a cell biology research tool that inhibits protein interactions. It is a small …
Fórmula:
C47H56ClF3N6O5S3
Pureza:
Min. 95%
Peso molecular:
973.6 g/mol
Ref: 3D-TKD09693
| 2mg | 817,00 € | ||
| 5mg | 1.230,00 € | ||
| 10mg | 1.670,00 € | ||
| 25mg | 2.672,00 € | ||
| 50mg | 4.008,00 € |
Entrega estimada en Estados Unidos, el Viernes 28 de Febrero de 2025
